Fundraising FoxIllumentx
1 known investors
Find your way into Illumentx
Illumen Therapeutics is a biotech company developing first-in-class PARN inhibitor drugs that increase functional p53, a tumor suppressor, as a treatment for aggressive cancers. Its drug development focuses on targeting p53 dysregulation to improve cancer patient survival.
Investors · 1
Frequently asked questions
- What does Illumentx do?
- Illumen Therapeutics is a biotech company developing first-in-class PARN inhibitor drugs that increase functional p53, a tumor suppressor, as a treatment for aggressive cancers. Its drug development focuses on targeting p53 dysregulation to improve cancer patient survival.
- Who are Illumentx's investors?
- Illumentx's investors include Colorado BioScience Association.